Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Microport Scientific Corp

+ Add to Watchlist

853:HK

4.410 HKD 0.060 1.38%

As of 03:29:44 ET on 05/27/2015.

Snapshot for Microport Scientific Corp (853)

Open: 4.390 Day's Range: 4.360 - 4.430 Volume: 1,846,115
Previous Close: 4.350 52wk Range: 3.090 - 5.490 1-Yr Rtn: -18.03%

Stock Chart for 853

No chart data available.
  • 853:HK 4.410
  • 1D
  • 1M
  • 1Y
4.350
Interactive 853 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 853

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. HSI -
Earnings Per Share (USD) (ttm) -0.0422
Est. EPS (USD) (12/2015) -0.0010
Est. PEG Ratio -
Market Cap (M HKD) 6,259.39
Shares Outstanding (M) 1,422.59
30 Day Average Volume 2,312,303
Price/Book (mrq) 2.3638
Price/Sale (ttm) 2.2551
Dividend Indicated Gross Yield -%
Cash Dividend (HKD) -
Dividend Ex-Date 06/29/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 853

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 853

Microport Scientific Corp. manufactures interventional and minimally invasive devices for keyhole surgery. The Company's products are used to treat vascular diseases and is developing devices to treat diabetes and orthopedic diseases.

Zhaohua ChangChairman/CEO/FounderHongbin SunChief Financial Officer
Qiyi LuoChief Technology OfficerJunder ChiangChief HR Ofcr
More Company Profile & Key Executives for 853

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil